Seillac
Scientific Program
Seillac, October 2018
October 8th
19:00 - 22:00 : Welcome dinnerOctober 9th
08:30 : RegistrationChair : Francesco di Virgilio (WG2 Leader)
8:50 - 9:00 : Introduction WG2
9:00 - 10:00 : Plenary lecture Antonio Curti (IT)
10:00 - 10:20 : Sana Kouba : The interaction between the ORAI3 calcium channel and STIM2 contributes to Prostate Cancer cell proliferation and survival.
10:20 - 11:00 : Biljana Bozic : Vitamin B complex therapy attenuates neuroinflammation after peripheral nerve injury : A mediating role of L-type CaV1.2 calcium channels
11:00 - 11:30 : Break
11:30 - 12:00 : Nelig Le Goux : A consitutive Ca2+ pathway drives chronic lymphocytic leukemia outcome and is reversed by an anti-STIM1 monoclonal antibody.
12:00 - 12:30 : Nuray Erin: CD200 mimetics as a new therapeutic approach for metastatic breast carcinoma resistant to conventional treatments.
12:30 - 14:00 : Lunch
14:00 - 14:30 : Elena De Marchi: P2X7 receptor modulates eATP levels, ectonucleotidases expression and immune cell infiltrate in the tumor microenvironment.
14:30 - 15:00 : Vladislavs Jasinski: The association of IFN-γ production with the level of ORAI1 gene expression in patients with HIV-associated tuberculosis (Pilot Study).
15:30 - 16:00 : Sanja Pekovic :Mediating Role of L-type CaV1.2 Calcium Channels in favourable effects of Vitamin B complex therapy on recovery after peripheral nerve injury.
16:00 - 16:30 : Break
16:30 - 18:00 : MC Meeting
19:30 - 22:00 : Gala dinner (President of University)
October 10th
Chair : Ruth Murell-Lagnado (WG1 Leader)8:50 - 9:00 : Introduction WG1
09:00 - 10:00 : Plenary lecture Andreas Guse (Ger)
10:00 - 10:20 : Valentina Vultaggio :P2X7R: a key role in the generation of an ATP-rich TME driven by nutrient deprivation.
10:20 - 11:00 : Iva Hafner Bratkovic : Molecular mechanisms of NLRP3 activation and inhibition: the roles of NLRP3 domains and extracellular pH.
11:00 - 11:30 : Break
11:30 - 12:00 : Olzen Konu : Expression profiling and co-culture studies of microRNAs and cholinergic receptor subunit CHRNA5.
12:00 - 12:30 : Orsolya Voros :The role of Kv1.3 C-terminus in the gating and plasma membrane targeting.
12:30 - 14:00 : Lunch
Chair : Freidrich Koch-Nolte (WG3 Leader)
14:00 - 14:10 : Introduction WG3
14:10 - 14:40 : Katja Ester :Crown ether compound 613 as a small molecule with good antitumor potential: investigation of membrane perturbation and changes in ion homeostasis.
14:40 - 15:10 : Agota Csoti : Characterization of a novel high-selectivity Kv1.3 inhibitor peptide.
15:10 - 15:40 : Eitan Reuveny : Nature utilization of the slow inactivation mechanism in voltage gate K channels.
15:40 - 16:10 : Marten Junge :The P2X7 ion channel renders kidney resident CD4 T cells and NKT cells sensitive to nucleotide induced cell death.
16:30 - 17:00 : Break
17:00 - 18:00 : Conference on EUROPE projects
19:00 - 20:30 : Convivial dinner
20:30 - 21:30 : Concert
October 11th
11:00 : Departure
